CAS: 21187-98-4 - Benzenesulfonamide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-
Formula:C15H21N3O3S
InChI:InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)
InChI key:InChIKey=BOVGTQGAOIONJV-UHFFFAOYSA-N
SMILES:O=C(NN1CC2CCCC2C1)NS(=O)(=O)C3=CC=C(C=C3)C
- Synonyms:
- 1-(3,3a,4,5,6,6a-Hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea
- 1-(4-Methylbenzenesulfonyl)-3-[octahydrocyclopenta[c]pyrrol-2-yl]urea
- 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
- Cyclopenta[c]pyrrole, benzenesulfonamide deriv.
- Diabezidum
- Diabrezide
- Diabyl
- Diamicron
- Diaprel
- Gliclazid
- See more synonyms
- Gliclazida
- Gliclazide
- Glimicron
- Glinormax
- Glyzide
- N-(4-Methylbenzenesulfonyl)-N'-[3-azabicyclo(3,3,0)oct-3-yl]urea
- N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methylbenzenesulfonamide
- S 1702
- S 852
- Se 1702
- Urea, 1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-
Gliclazide
CAS:21187-98-4
Formula:
C15H21N3O3S
Purity:
>98.5%(T)(HPLC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
323.41
Ref: 3B-G0381
5g | 73.00 € |
Estimated delivery in United States, on Wednesday 27 Nov 2024
Gliclazide CRS
CAS:21187-98-4
Formula:
C15H21N3O3S
Color and Shape:
White. Powder.
Molecular weight:
323.4105
Ref: 41-G0326000
20mg | 115.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
Gliclazide
CAS:21187-98-4
Formula:
C15H21N3O3S
Purity:
99.8%
Color and Shape:
White Solid
Molecular weight:
323.13036
Ref: 47-368
200mg | 242.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
Benzenesulfonamide,N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-
CAS:21187-98-4
Formula:
C15H21N3O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
323.4105
Ref: IN-DA00I41T
1g | 27.00 € | ||
5g | 34.00 € | ||
25g | 56.00 € | ||
100g | 109.00 € | ||
500g | 333.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Gliclazide
CAS:21187-98-4
Gliclazide (SE1702), an oral antihyperglycemic agent, belongs to the sulfonylurea class of insulin secretagogues, which …
Formula:
C15H21N3O3S
Purity:
98.08%
Color and Shape:
Solid
Molecular weight:
323.41
Ref: TM-T1527
1g | 77.00 € | ||
500mg | 54.00 € | ||
1mL*10mM (DMSO) | 55.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Gliclazide-d7
CAS:21187-98-4
Formula:
C15H14N3O3SD7
Color and Shape:
White To Off-White Solid
Molecular weight:
330.46
Ref: 4Z-G-058
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 7W-GP9297
Undefined size | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Gliclazide
CAS:21187-98-4
Formula:
C15H21N3O3S
Color and Shape:
White To Off-White Solid
Molecular weight:
323.41
Ref: 4Z-G-052
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Gliclazide
Controlled ProductCAS:21187-98-4
Formula:
C15H21N3O3S
Color and Shape:
Neat
Molecular weight:
323.41
Ref: 86-MM0325.00-0250
250mg | 869.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 04-C14025500
100mg | 114.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Gliclazide
CAS:21187-98-4
Applications A sulfonylurea hypoglycemic agent. Used as an antidiabetic. References Duhault, J., et al.: Arzneimittel-Forsch., …
Formula:
C15H21N3O3S
Color and Shape:
Neat
Molecular weight:
323.41
Ref: TR-G409875
1g | 155.00 € | ||
5g | 173.00 € | ||
50mg | 89.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Gliclazide
CAS:21187-98-4
Inhibitor of sulfonylurea receptor SUR1
Formula:
C15H21N3O3S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
323.41 g/mol
Ref: 3D-FG23666
10g | 136.00 € | ||
25g | 151.00 € | ||
50g | 213.00 € | ||
100g | 340.00 € | ||
250g | 463.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024